|
⚲
|
| Keyboard |
| Paul Grayson | |
|---|---|
| Firm | |
| Address | 11250 El Camino Real Suite 100 San Diego, CA 92130 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Skye Bioscience Inc | 021-508708 | Director | 40.0 M of 40.0 M |
||
| Skye Bioscience Inc | 021-504974 | Director | 50.0 M of 50.0 M |
||
| Tentarix Biotherapeutics LP | 021-491553 | Executive Officer | 35.0 M of 35.0 M |
||
| Skye Bioscience Inc | 021-490948 | Director | 62.3 M of 62.3 M |
||
| Tentarix Biotherapeutics LP | 021-375611 | Executive Officer | 8.0 M of 50.0 M |
||
| Tempest Therapeutics Inc | 021-306741 | Director | 83.2 M of 100.2 M |
||
| Bird Rock Bio Inc | 021-277896 | Executive Officer | 2.5 M of 2.5 M |
||
| Bird Rock Bio Inc | 021-256654 | Executive Officer | 5.0 M of 30.0 M |
||
| Fullfunxn Inc | 021-249122 | Director | 0.7 M of 0.7 M |
||
| Fullfunxn Inc | 021-236670 | Director | 0.0 M of 0.2 M |
||
| Ruiyi Inc | 021-214597 | Executive Officer | 5.0 M of 15.0 M |
||
| Anaphore Inc | 021-166939 | Executive Officer | 0.1 M of 0.1 M |
||
| Fate Therapeutics Inc | 021-117892 | Executive Officer | 36.0 M of 36.0 M |
||
| Anaphore Inc | 021-117838 | Executive Officer | 39.9 M of 39.9 M |
||
| Receptos Inc FKA Receptor Pharmaceuticals Inc | 021-131445 | Director | 12.0 M of 20.0 M |
||